APOE and Schnyder corneal dystrophy: The efficacy of EGCG in combination with multimodal intervention (dietary guidance, physical exercise, psychoeducation, social activities and cognitive training) in slowing down cognitive decline was assessed in the PENSA study in APOE-ε4 carriers with SCD (NCT03978052, Table 1) [50].